Noteworthy

Noteworthy

Oct 30, 2020

Klaus Ley receives $2.3 million to study fundamentals of immune cell activation

New research could shed light on how immune cells can better fight cancers or step back in autoimmune disease
Oct 27, 2020

Lynn Hedrick receives more than $500,000 for COVID-19 research

New immune cell studies may shed light on heart attacks, inflammation seen in COVID-19 patients
Feb 27, 2020

La Jolla Institute Board of Directors elects semiconductor industry pioneer

Former AMCC Chair and CEO David M. Rickey joins Institute Board
Feb 27, 2020

La Jolla Institute Board of Directors elects leading health care attorney

Foley & Lardner partner J. Mark Waxman joins Institute Board
Jan 22, 2020

iMAP of human atherosclerosis shortlisted for £30m research prize

The proposed iMAP will reveal new targets for immunotherapy, and may lead to a new wave of medicines and vaccines that can prevent heart attacks and strokes; La Jolla Institute for Immunology researcher Klaus Ley and Scripps researcher Eric Topol are key members of the iMAP team.